Fierce Biotech Webinar “Alzheimer’s Outlook – Neuroinflammation, the Next Step” is now available on demand.
InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, joins a panel of experts to speak about recent breakthroughs in Alzheimer’s disease research and the effects of neuroinflammation in disease progression.
Alzheimer’s disease research experts come together for this informative session. Learn about:
- Role of neuroinflammation in the development of cognition-impairing disease
- Biological pathways to developing drugs to address neuroinflammation
- Why neuroinflammation is an important target for novel Alzheimer’s treatments
- Importance of patient diversity in clinical trial design
- Scanning the horizon – what to expect in the next 5 years
If you are a neurodegenerative disease researcher or clinician or study brain health or are a caregiver for someone living with Alzheimer’s disease, watch this webinar to learn what the future holds in Alzheimer’s disease therapeutic development.
Speakers for this event:
- Phyllis Ferrell, DrPH, MBA (Moderator), Chief Impact Officer at StartUp Health’s Alzheimer’s Moonshot
- David Morgan, PhD, Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University
- Marwan Sabbagh, MD, Moreno Family Chair for Alzheimer’s Research and Vice Chairman for Research and Professor of Neurology at the Barrow Neurological Institute in Phoenix Arizona
- Barry Greenberg, PhD, Associate Professor in the Department of Neurology and Director of Alzheimer’s Disease Translational Center at the Johns Hopkins University School of Medicine
- Eric Hsu, PhD, Senior Vice President of Preclinical Research and Development at InMed Pharmaceuticals
